# A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids

> **NCT02814019** · PHASE3 · TERMINATED · sponsor: **Santhera Pharmaceuticals** · enrollment: 255 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy (DMD)

## Interventions

- **DRUG:** Idebenone 150 mg film-coated tablets
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02814019
- **Lead sponsor:** Santhera Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-09
- **Primary completion:** 2020-12-01
- **Final completion:** 2020-12-01
- **Target enrollment:** 255 (ACTUAL)
- **Why stopped:** Interim analysis concluded to futility
- **Last updated:** 2021-12-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02814019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02814019, "A Phase III Double-blind Study With Idebenone in Patients With Duchenne Muscular Dystrophy (DMD) Taking Glucocorticoid Steroids". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02814019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*